Armata Pharmaceuticals
ARMP
25 hedge funds and large institutions have $473K invested in Armata Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
11% more capital invested
Capital invested by funds: $427K → $473K (+$46K)
4% more funds holding
Funds holding: 24 → 25 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$54.6K |
| 2 |
Stifel Financial
St. Louis,
Missouri
|
+$28.9K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$13.6K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.89K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$4.71K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$168K |
| 2 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$10K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$9.51K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$6.29K |
| 5 |
Morgan Stanley
New York
|
-$129 |
ARMP Hedge Fund Activity: Q1 2019 in Review
25 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Armata Pharmaceuticals (ARMP) for Q1 2019, worth a combined $473K — up 11% from $427K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ARMP positions and 3 closed out — a net gain of 1 holder — while 4 added to existing stakes and 3 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $54.6K. The largest seller was Sabby Management, exiting entirely with an estimated $168K sold.
- 25 institutional investors held Armata Pharmaceuticals (ARMP) as of Q1 2019, up from 24 in Q4 2018.
- Funds reported $473K of Armata Pharmaceuticals stock for Q1 2019, up 11% quarter-over-quarter.
- 4 funds opened new Armata Pharmaceuticals positions in Q1 2019 and 3 closed out, a net change of +1 holder.
- The largest Armata Pharmaceuticals buyer in Q1 2019 was Renaissance Technologies, an estimated $54.6K added.
- The largest Armata Pharmaceuticals seller in Q1 2019 was Sabby Management, an estimated $168K sold.
Based on aggregated 13F filings for Q1 2019.